Skip to content
  • 6,813 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Award notice, first published as combined synopsis and solicitation

Reagents for detection of Mycobacterium Tuberculosis: Liaison QuantiFERON TB Gold Plus and LIAISON Control QuantiFERON TB Gold Plus

W81K0225QA107

Department of the Army, W40M Mrco Pacific. In-Vitro Diagnostic Substance Manufacturing.

13 open like this View on SAM.gov Markdown

Awarded

Qiagen, LLC

$485,895.00 on the award notice, September 17, 2025, contract W81K0225DA026

Get the next one like this from Department of the Army by email, the day it is posted.Find my opportunities

This one was awarded in 2025

13 like it are open now in in-vitro diagnostic substance manufacturing

All 13 open in in-vitro diagnostic substance manufacturing

Description

As published on SAM.gov.

On 17 September 2025, Joint Base Lewis McChord Health Contracting Branch awarded sole source Indefinite Delivery Indefinite Quantity to Qiagen, LLC, 19300 Germantown Road Germantown, MD 20874-1415 for supplies: QuantiFERON TB Gold-Plus assay reagents for running QuantiFERON TB-Gold Plus for the detection of Mycobacterium Tuberculosis immune responses by enzyme immunoassay (EIA), for Madigan Army Medical Center, Tacoma WA 98431. This award was in accordance with FAR 13.106-l(b)(l). IAW FAR 5.301 this serves as the award notice under Solicitation W81K0225QA107 resulting in Contract Award W81K0225DA026. The North American Industry Classification Systems (NAICS) code for this work is 325413, with business size standard of 1,250 employees. The NAICS is for In-Vitro Diagnostic Substance Manufacturing. The Product Service Code (PSC) is 6550. The resulting contract has an order period of 01 October 2025- 30 September 2030 and the contract ceiling amount is $485,895.00. See attached J&A for further information.

Attachments

Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Qiagen, LLC
UEI
W2GLKC92ZH73
CAGE
01QT0
Vendor location
Germantown, MD
Contract
W81K0225DA026
Obligated
$0.00, potential $489,895
Actions
3 between September 17, 2025 and April 14, 2026
Competition
Not Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Quantiferon TB Gold-Plus Assays (Reagents and Controls) for the Detection of Mycobacterium Tuberculosis.
Match
award number W81K0225DA026 equals the contract number; same awarding office W81K02 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 16, 2025

    Combined synopsis and solicitation, originally sources sought

    Due September 17, 2025 at 2:00 PM EDT. SAM.gov, notice eb7e8e8c431d42a396fc15f7bb3eb17e

    3 revisions on SAM
    • September 17, 2025: publish, award notice
    • September 16, 2025: publish, combined synopsis and solicitation
    • August 21, 2025: publish, sources sought

  2. September 17, 2025

    Award notice, originally combined synopsis and solicitation

    Awarded to Qiagen, LLC for $485,895. SAM.gov, notice 3e174cfc24014b4e9e68a1fc53bc8bb5

    2 revisions on SAM
    • September 17, 2025: publish, award notice
    • September 16, 2025: publish, combined synopsis and solicitation

Points of contact